Drugs. 2015 Sep;75(14):1669-78. doi: 10.1007/s40265-015-0468-9. Author information 1 Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand. demail@springer.com. Abstract Oral eliglustat (Cerdelga®) is approved in several countries for the long-term treatment of adults with Gaucher disease type 1 (GD1)[…]
[ncbi.nlm.nih.gov]